EUVIMEDEUVIMED entdecken
Crossref

Low Molecular Weight Heparins Can Lead To Hyperkalaemia

The Internet Journal of Geriatrics and Gerontology · 2005

DOI: 10.5580/10be ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Internet Journal of Geriatrics and Gerontology, 2005.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Low molecular weight heparins (LMWH) have an important role in the management of many clinical conditions, either prophylactically or therapeutically.1,2,3 They are known to cause side-effects such as haemorrhage, thrombocytopenia, hypersensitivity reactions, skin necrosis and osteoporosis.1 Hyperkalaemia is a recognised side-effect of heparin and LMWH use, but this may be easily overlooked in a clinician's day-to-day practise.1,2,3,4,5 A case of Clexane (enoxaparin) induced hyperkalaemia in an elderly patient on a surgical ward is described.

Zitieren

APA

(2005). Low Molecular Weight Heparins Can Lead To Hyperkalaemia. The Internet Journal of Geriatrics and Gerontology. https://doi.org/10.5580/10be

Vancouver

Low Molecular Weight Heparins Can Lead To Hyperkalaemia. The Internet Journal of Geriatrics and Gerontology. 2005. doi:10.5580/10be

BibTeX
@article{euvimed2005,
  title = {Low Molecular Weight Heparins Can Lead To Hyperkalaemia},
  journal = {The Internet Journal of Geriatrics and Gerontology},
  year = {2005},
  doi = {10.5580/10be}
}
Kostenlos starten →